Company: FENC
Filing Date: 2025-02-07
Form Type: 8-K
Source: 0001558370-25-000715
Chunk: 0

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-02-07
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01.      Other Events.  

On February 7, 2025, Fennec Pharmaceuticals Inc. issued a news release announcing that Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, has commercially launched PEDMARQSIÒ(sodium thiosulfate injection) in Germany. A copy of the news release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Current Report on Form 8-K, including the exhibit attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “ Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, unless such subsequent filing specifically references this Form 8-K.